Research on age-related cognitive impairment is scarce in Central America. We report factors associated with cognitive impairment among a sample of older adults in Panama diagnosed with Alzheimer’s disease (AD, n = 31), mild cognitive impairment (MCI, n = 43), or no cognitive impairment (controls, n = 185). Apolipoprotein E (ApoE) genotype was assessed in a subset of cases (n = 135). Age (OR = 2.53, 95% CI = 1.03–6.17) and ApoE ɛ4 (OR = 5.14, 95% CI = 2.11–12.52) were significantly related to cognitive impairment (AD/MCI combined). Results underscore the potential of genetic screening in Panama for identifying those at risk of dementia.
FerriCP, PrinceM, BrayneC, BrodatyH, FratiglioniL, GanguliM, HallK, HasegawaK, HendrieH, HuangY, JormA, MathersC, MenezesPR, RimmerE, ScazufcaM (2005) Global prevalence of dementia: A Delphi consensus study. Lancet366, 2112–2117.
2.
NitriniR, BottinoCM, AlbalaC, Custodio CapunayNS, KetzoianC, Llibre RodriguezJJ, MaestreGE, Ramos-CerqueiraAT, CaramelliP (2009) Prevalence of dementia in Latin America: A collaborative study of population-based cohorts. Int Psychogeriatr21, 622–630.
3.
SosaAL, AlbaneseE, StephanBC, DeweyM, AcostaD, FerriCP, GuerraM, HuangY, JacobKS, Jimenez-VelazquezIZ, RodriguezJJ, SalasA, WilliamsJ, AcostaI, Gonzalez-ViruetM, HernandezMA, ShuranL, PrinceMJ, StewartR (2012) Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: A 10/66 population-based study. PLoS Med9, e1001170.
4.
VillarrealAE, GrajalesS, LópezL, BrittonGB, Panama Aging Research Initiative (2015) Cognitive impairment, depression, and cooccurrence of both among the elderly in Panama: Differential associations with multimorbidity and functional limitations. BioMed Res Int2015, 7.
5.
PalloniA, McEniryM (2007) Aging and health status of elderly in Latin America and the Caribbean: Preliminary findings. J Cross Cult Gerontol22, 263–285.
6.
FarrerLA, CupplesLA, HainesJL, HymanB, KukullWA, MayeuxR, MyersRH, Pericak-VanceMA, RischN, van DuijnCM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA278, 1349–1356.
7.
ArboledaGH, YunisJJ, PardoR, GomezCM, HedmontD, ArangoG, ArboledaH (2001) Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer’s disease. Neurosci Lett305, 135–138.
8.
CamposM, EdlandSD, PeavyGM (2013) Exploratory study of apolipoprotein E epsilon4 genotype and risk of Alzheimer’s disease in Mexican Hispanics. J Am Geriatr Soc61, 1038–1040.
9.
SevushS, PeruyeraG, CrawfordF, MullanM (2000) Apolipoprotein-E epsilon 4 allele frequency and conferred risk for Cuban Americans with Alzheimer’s disease. Am J Geriatr Psychiatry8, 254–256.
10.
FolsteinMF, FolsteinSE, McHughPR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
11.
TaussigIM, MackWJ, HendersonVW (1996) Concurrent validity of Spanish-language versions of the Mini-Mental State Examination, Mental Status Questionnaire, Information-Memory-Concentration test, and Orientation-Memory-Concentration test: Alzheimer’s disease patients and nondemented elderly comparison subjects. J Int Neuropsychol Soc2, 286–298.
12.
BlesaR, PujolM, AguilarM, SantacruzP, Bertran-SerraI, HernándezG, SolJM, Peña-CasanovaJ, Group NORMACODEM, NORMAlisation of Cognitive, Functional Instruments for, DEMentia (2001) Clinical validity of the ‘mini-mental state’ for Spanish speaking communities. Neuropsychologia39, 1150–1157.
13.
RoyallDR, EspinoDV, PolkMJ, VerdejaR, ValeS, GonzalesH, PalmerRR, MarkidesKP (2003) Validation of a Spanish translation of the CLOX for use in Hispanic samples: The Hispanic EPESE study. Int J Geriatr Psychiatry18, 135–141.
14.
YesavageJA, BrinkTL, RoseTL, LumO, HuangV, AdeyM, LeirerVO (1982) Development and validation of ageriatric depression screening scale: A preliminary report. J Psychiatr Res17, 37–49.
15.
IzalM, MontorioI (1993) Adaptation of the Geriatric Depression Scale in Spain: Areliminary study. Clin Gerontol13, 83–91.
16.
ReisbergB, FerrisSH, de LeonMJ, CrookT (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry139, 1136–1139.
17.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
18.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
19.
KochW, EhrenhaftA, GriesserK, PfeuferA, MullerJ, SchomigA, KastratiA (2002) TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med40, 1123–1131.
20.
HaanMN, MungasDM, GonzalezHM, OrtizTA, AcharyaA, JagustWJ (2003) Prevalence of dementia in older Latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc51, 169–177.
21.
O’BryantSE, JohnsonL, BalldinV, EdwardsM, BarberR, WilliamsB, DevousM, CushingsB, KneblJ, HallJ (2013) Characterization of Mexican Americans with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis33, 373–379.
22.
TangMX, SternY, MarderK, BellK, GurlandB, LantiguaR, AndrewsH, FengL, TyckoB, MayeuxR (1998) The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA279, 751–755.
23.
Ruiz-LinaresA, AdhikariK, Acuna-AlonzoV, Quinto-SanchezM, JaramilloC, AriasW, FuentesM, PizarroM, EverardoP, de AvilaF, Gomez-ValdesJ, Leon-MimilaP, HunemeierT, RamalloV, Silva de CerqueiraCC, BurleyMW, KoncaE, de OliveiraMZ, VeronezMR, Rubio-CodinaM, AttanasioO, GibbonS, RayN, GalloC, PolettiG, RosiqueJ, Schuler-FacciniL, SalzanoFM, BortoliniMC, Canizales-QuinterosS, RothhammerF, BedoyaG, BaldingD, Gonzalez-JoseR (2014) Admixture in Latin America: Geographic structure, phenotypic diversity and self-perception of ancestry based on 7,342 individuals. PLoS Genet10, e1004572.
24.
DownerB, RajiMA, MarkidesKS (2016) Relationship between metabolic and vascular conditions and cognitive decline among older Mexican Americans. Int J Geriatr Psychiatry31, 213–221.
25.
SalazarR, RoyallDR, PalmerRF (2015) Neuropsychiatric symptoms in community-dwelling Mexican-Americans: Results from the Hispanic Established Population for Epidemiological Study of the Elderly (HEPESE) study. Int J Geriatr Psychiatry30, 300–307.
